Silodosin 4mg versus tamsulosin 0.2mg once daily; randomized crossover study

Trial Profile

Silodosin 4mg versus tamsulosin 0.2mg once daily; randomized crossover study

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Silodosin (Primary) ; Tamsulosin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 08 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top